arrow
M

Michel Ducreux

medical oncology
H指数:116
被引数:6.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Targeting the Liver: Insights from a tertiary center on post-operative hepatic arterial oxaliplatin for Metastatic Colorectal Cancer

靶向肝脏:来自一家三级中心关于转移性结直肠癌术后肝动脉奥沙利铂灌注的见解

2026-03-030
PRE
Lung-only metastatic pancreatic cancer: differences in patients ‘characteristics, molecular profile and survival

肺转移性胰腺癌:患者特征、分子谱和生存差异

2026-01-090
PRE
Comprehensive molecular landscape of anal squamous cell carcinoma: analysis of tissue and liquid biopsies from 1844 patients

肛门鳞状细胞癌的全面分子图谱:1844例患者的组织活检和液体活检分析

2025-11-240
OAAI
Multimodal Management of Retroperitoneal Lymph Node Metastases in Colorectal Cancer: A Single-Center Retrospective Analysis

结直肠癌腹膜后淋巴结转移的多模式管理:一项单中心回顾性分析

2025-10-140
PRE
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with pancreatic cancer

泛亚洲适应性ESMO临床实践指南:胰腺癌患者的诊断、治疗和随访

2025-10-090
OAAI
Impact of oncology review meetings on second opinions for patients with gastrointestinal cancer

肿瘤学评审会议对胃肠道癌患者二次诊疗意见的影响

2025-09-200
PRE
ASO Visual Abstract: Multimodal Management of Retroperitoneal Lymph Node Metastases in Colorectal Cancer: A Single-Center Retrospective Analysis

ASO 视觉摘要:结直肠癌腹膜后淋巴结转移的多模式管理:一项单中心回顾性分析

2025-09-050
PRE
Summary Intercontinental Multidisciplinary Oncology Videoconferencing between the South Pacific and the French mainland: Reasons for medical evacuation after more than 2000 cases of cancers discussed

摘要:南太平洋与法国本土之间的洲际多学科肿瘤学视频会议:讨论超过2000例癌症病例后的医疗转运原因

2025-09-010
PRE
Young-Onset Biliary Tract Cancers: Characteristics, Treatment Patterns, and Patient Outcomes

早发型胆道系统癌症:特征、治疗模式及患者预后

2025-08-110
OAAI
Collagenous colitis in patients treated for cancer: role of immune checkpoint inhibitors. Clinical, histological and immunological features in 15 cases

胶原性结肠炎在癌症治疗患者中的发生:免疫检查点抑制剂的潜在作用。15例患者的临床、组织学和免疫学特征

2025-08-060
OAAI
Durvalumab and tremelimumab plus local partial tumour ablation (radiofrequency ablation or stereotactic radiotherapy) in patients with unresectable liver metastases from metastatic colorectal cancer: results of the EORTC-1560-GITCG multicentre, single-arm phase II study (ILOC)

度鲁妥单抗和特瑞普利单抗联合局部部分肿瘤消融(射频消融或立体定向放疗)在转移性结直肠癌不可切除性肝转移患者中的应用:EORTC-1560-GITCG多中心、单臂II期研究(ILOC)的结果

2025-07-230
PREAI
Bevacizumab-based chemotherapy adaptive to pharmacokinetic of bevacizumab in first-line treatment of patients with unresectable metastatic colorectal cancer: A double-blind, multicenter, randomized phase III trial study (PHARBEVACOL trial)

基于贝伐珠单抗的化疗,根据贝伐珠单抗药代动力学适应性调整,用于不可切除性转移性结直肠癌患者的一线治疗:一项双盲、多中心、随机III期临床试验研究(PHARBEVACOL试验)

2025-05-010
OAAI
Predictive factors of FOLFIRINOX chemotherapy toxicity in pancreatic adenocarcinoma patients

胰腺癌患者FOLFIRINOX化疗毒性的预测因素

2025-02-090
PRE